Cabaletta Bio (CABA) Other Operating Expenses (2023 - 2026)

Cabaletta Bio (CABA) posted quarterly Other Operating Expenses of -$79000.0 for Q4 2025, down 115.86% quarter-over-quarter from $498000.0 in Q3 2025.

Cabaletta Bio (CABA) Other Operating Expenses (2023 - 2026) Analysis & Trends

Cabaletta Bio's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$79000.0 for Q4 2025.

In Q4 2025, Other Operating Expenses changed N/A year-over-year to -$79000.0; the TTM figure through Dec 2025 stood at $28.8 million (up 33.58% YoY), while the FY2025 annual figure was $358000.0, changed N/A from the prior year.
Other Operating Expenses for Q4 2025 stood at -$79000.0, down from $498000.0 in the prior quarter.
The five-year high for Other Operating Expenses was $54.0 million in Q4 2023, with the low at -$79000.0 in Q4 2025.
The 3-year median for Other Operating Expenses is $11.0 million (2024), against an average of $17.4 million.
Peak annual rise in Other Operating Expenses reached 31.92% in 2025, while the deepest fall reached 31.92% in 2025.
Cabaletta Bio's Other Operating Expenses stood at $54.0 million in 2023, then tumbled by 60.06% to $21.6 million in 2024, then plunged by 100.37% to -$79000.0 in 2025.
Business Quant data shows CABA's Other Operating Expenses at -$79000.0 in Q4 2025, $498000.0 in Q3 2025, and -$61000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Cabaletta Bio	466.25 Mn	466.25 Mn	-

Download Data